Hi team,
Wanted to keep you updated, looks like PYC has made a good breakthrough - this seems a wide CNS catch all kind of patent. I hope they can land this, as it’ll be a huge leap forward for science if they’ve found a replicable/scaleable intracellular treatment platform - very valuable if so.
Trying to not get too excited as we’re in the midst of tax loss selling season as TB highlighted.
Ann: PK STUDY RESULTS MOVE RP11 CLOSER TO FIRST IN HUMAN TRIALS, page-65
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.15 |
Change
0.020(1.77%) |
Mkt cap ! $670.7M | |||
| Open | High | Low | Value | Volume |
| $1.15 | $1.18 | $1.11 | $172.3K | 151.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 592 | $1.15 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.16 | 4211 | 1 |
View Market Depth
| Last trade - 16.10pm 20/06/2025 (20 minute delay) ? |
| PYC (ASX) Chart |